Monday, August 24, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
RegulatoryAbbVie Launches Phase 2 Forehead Lines StudytodayMarketFacial Rejuvenation Market Forecast to Hit $5.66B by 20302 days agoBusiness & M&AAllergan Aesthetics Overhauls Loyalty ProgramtodayDevices & TechXERF Technology Enters Australian Market for Skin Tightening2 days agoBusiness & M&AEvolus Expands Estyme to Canada, Australia, New ZealandtodayMarketArm Fat Now Top Body Sculpting Concern in Singapore2 days agoDevices & TechSofwave Hits One Million Treatments MilestonetodayRegulatoryCKD Bio Pursues China Botox Approval—2027 Launch Targeted2 days agoRegulatoryRevance Wins FDA Nod for Under-Eye InjectablesyesterdayMarketGLP-1 Pill Era Is Forcing Beauty Market ShiftyesterdayInjectablesAEON Releases Expanded ABP-450 Botox Biosimilar DatayesterdayDevices & TechUltherapy PRIME Real-Time Imaging Reshapes Midface Liftingyesterday
Government Mechanics

NDAA

The annual defense policy law that authorizes weapons programs and sets Pentagon priorities Congress will fund.

Also known as: National Defense Authorization Act, Defense Authorization

What it is
The NDAA is the yearly law that authorizes Department of Defense programs, spending levels, and policy. It sets ceilings and directs which platforms and initiatives get pursued. Actual money still comes through defense appropriations.
What it does
The NDAA telegraphs which weapons systems, shipbuilding lines, and technologies have congressional backing, guiding investor expectations for primes and suppliers. Program adds and cuts inside the bill move exposed names. It is a roadmap for the appropriations that follow.
The evidence
Shipbuilders and aircraft primes have moved on NDAA provisions adding or accelerating platforms they produce.
Best for
Defense primes like LMT, NOC, GD, HII, RTX; ETF ITA.
Pairs well with
appropriations, foreign-military-sale, usaspending
Use cautiously with
Authorization is not appropriation; an NDAA add without matching appropriated dollars produces no revenue.
Cautions
The bill's provisions are negotiated to the wire, so early drafts can mislead single-name theses.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo